Product Information

EZETIMIBE 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0786 per EA under NDC 00781569092. Its NADAC has been published 365 times since Aug 9, 2017.

The High Outlier badge above means this manufacturer's average price in the Ezetimibe market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

EZETIMIBE 10 MG TABLET

Ezetimibe
$0.0786per EA
High Outlier

Strength

10 mg/1

Manufacturer

Sandoz Inc.

NDC

00781569092

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

7/17/2024

Active Ingredients

EZETIMIBE

Approval Type

Generic (ANDA)

FDA Application

ANDA203931

On Market Since

6/12/2017

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor

Price Statistics

The NADAC for EZETIMIBE 10 MG TABLET has been published 365 times since Aug 9, 2017, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0786 per EA
All-time high$6.9413 (Aug 16, 2017)
All-time low$0.0718 (May 22, 2024)
Median price$0.1545
Average price$0.2482
Largest weekly change-88.2% (Sep 20, 2017)
Weeks tracked365
Tracking sinceAug 9, 2017

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-11.0%

5Y

-49.1%

All

-98.9%

Generic Alternatives

The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of EZETIMIBE 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Sandoz Inc., is $0.0786 per EA (NDC 00781569092), effective Jul 31, 2024.

How has the price of EZETIMIBE 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 98.9%. It has been tracked across 365 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?

Since Aug 9, 2017, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0718 (May 22, 2024) to a high of $6.9413 (Aug 16, 2017), with a median of $0.1545 per EA.

Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?

Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0691 per EA — about 12% below EZETIMIBE 10 MG TABLET.

Who manufactures EZETIMIBE 10 MG TABLET?

EZETIMIBE 10 MG TABLET (NDC 00781569092) is labeled by Sandoz Inc., and CMS classifies it as a generic product.